AstraZeneca PLC, GlaxoSmithKline Hook up with Academia for Inflammation Research and Creates Inflammation Research Centre

UK-based drug giants GlaxoSmithKline and AstraZeneca have linked arms with The University of Manchester under a unique collaboration that has created the Manchester Collaborative Centre for Inflammation Research (MCCIR), a translational centre for inflammatory diseases.

With funding of £5 million from each partner over three years, the project will hook up scientists from the pharmaceutical industry and academia allowing them to work together on inflammation research and translational medicine.

Back to news